Drug development

The development of biotechnologically produced drugs has made it possible to treat diseases at their cause, to do this more efficiently and with fewer side effects, or even to cure diseases. This is the focus of five biotechnology companies on Campus Berlin-Buch.

The spectrum of their drug development includes highly specific cancer antibodies (Glycotope GmbH), novel treatments targeting the cause of heart failure (Berlin Cures GmbH) or atrial fibrillation (OMEICOS Therapeutics GmbH), extremely effective antibiotics (MerLion Pharmaceuticals) and RNAi-based therapeutics for systemic cancers that can selectively regulate disease-related genes (Silence Therapeutics). Here, T-Knife, a spin-off from the Charité and the Max Delbrück Center, is developing one of the first T cell receptor gene therapies in Germany.

News innovation

OMEICOS’ OMT-28 Headed for Phase 3 in Primary Mitochondrial Diseases (PMD) Following Positive End-of-Phase 2 Meeting with the FDA

OMEICOS, a late-stage clinical biopharmaceutical company developing first-in-class small-molecule therapeutics for mitochondrial and inflammatory disorders, today announced the successful completion o...

more ...

A Leap into the World of Big Pharma

The Successful Transformation of a Startup: An Interview with Dr. Christian Regenbrecht, Vice President of Translational Oncology at GSK and Founder of CELLphenomics

more ...

Alithea Bio Scores Double Victory at VivaTech 2026 for Breakthrough in Preclinical Safety

Deep-tech biotech innovator Alithea Bio has achieved a spectacular double victory at VivaTech 2026, Europe’s largest startup and tech event, taking home both the coveted “Tech for Change” Jury Prize a...

more ...

Events Campus

27.08.2026, 10:00
CRISPR/Cas: Grundlagen und praktische Anwendung (Verschoben vom 4. Juni auf 27. August)

Der Crashkurs für Einsteiger*innen vermittelt die Grundlagen der CRISPR/Cas Technologie. Die Teilnehmer*innen sollen in die Lage versetzt werden, CRISPR/Cas Experimente selbständig zu planen und durch...

more ...

12.09.2026, 11:00
Tag des offenen Denkmals

Im Erdgeschoss des Oskar-und-Cécile-Vogt-Hauses sind wissenschaftliche Geräte aus einem Jahrhundert biomedizinischer Forschung ausgestellt, die Etappen der Medizin- und Forschungsgeschichte nachzeichn...

more ...

22.09.2026, 09:00
GMP Biotech Summer School

Knowing and applying the Good Manufacturing Practice (GMP) regulations is one of the key elements in the manufacture of medicinal products for clinical trials and on an industrial level.

more ...

Sponsoren der Website: